POINT BIOPHARMA GLOBAL INC. Proceeds from Common Stock Issued
POINT BIOPHARMA GLOBAL INC. reported Proceeds from Common Stock Issued of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $13.45M.
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $116.86M.
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for the quarter ending 2022-06-30 was -$942.00.
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $942.00.
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for fiscal 2022 was $130.31M, a 50.81% decline from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. proceeds from issuance of common stock for fiscal 2021 was $264.88M.
| Period end | Proceeds from Issuance of Common Stock 2 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | ||||
| 2022-12-31 | $13.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $130.31M derived: sum of 2 quarters · filed 2023-11-13 | $130.30M derived: sum of 3 quarters · filed 2023-11-13 | $130.31M 10-K · filed 2023-03-27 | |
| 2022-09-30 | $116.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $116.86M derived: sum of 2 quarters · filed 2023-11-13 | $116.86M 10-Q · filed 2023-11-13 | $116.86M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$942.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | -$544.24K derived: sum of 4 quarters · filed 2023-03-27 | |
| 2022-03-31 | $942.00 10-Q · filed 2022-05-13 | $942.00 derived: sum of 2 quarters · filed 2023-03-27 | -$543.29K derived: sum of 3 quarters · filed 2023-03-27 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$544.24K derived: sum of 2 quarters · filed 2023-03-27 | $264.88M 10-K · filed 2023-03-27 | ||
| 2021-09-30 | -$544.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $264.88M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $265.43M 10-Q · filed 2022-08-12 | ||||
| 2020-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-04 | $135.70M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $135.70M 10-Q · filed 2020-11-02 | ||||
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-20 |